Healthcare Services

Menopause Market Forecast Through 2030 Highlighting Market Trends And Industry Developments

April 23, 2026April 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Menopause Market In 2026 And 2030?

The menopause market size has seen significant growth in recent years. It is forecast to increase from $18.78 billion in 2025 to $19.95 billion in 2026, at a compound annual growth rate (CAGR) of 6.2%. The expansion observed in prior periods can be attributed to an aging female population, greater life expectancy among women, the widespread implementation of hormone replacement therapy, increasing recognition of menopausal symptoms, and the enhancement of women’s healthcare services.

The menopause market is projected to experience substantial expansion over the upcoming years, with its size anticipated to reach $26.21 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This projected growth is driven by several factors, including an increased demand for secure, long-term therapeutic options, the proliferation of digital health platforms dedicated to menopause, a heightened emphasis on preventive women’s health, broader availability of online pharmacies, and a wider acceptance of alternative and lifestyle-oriented treatments. Key trends expected during this period involve a greater uptake of non-hormonal treatments for menopause, enhanced awareness and proactive approaches to menopause management, a growing inclination towards dietary supplements and natural solutions, the development of personalized menopause care initiatives, and an elevated need for solutions targeting specific symptoms.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13190&type=smp

Which Key Drivers Are Affecting The Menopause Market Development?

A shift towards different ways of living and making choices that affect personal health and well-being, termed a changing lifestyle, is anticipated to boost the expansion of the menopause market going forward. Such lifestyle modifications, common during this natural biological stage, can significantly assist in managing menopausal symptoms and improving overall health. Women experiencing menopause often adopt various healthier habits, such as consuming a balanced diet, engaging in regular physical activity, ensuring adequate sleep, avoiding smoking and excessive alcohol consumption, and participating in relaxing activities. Supporting this trend, a press release by the Global Wellness Institution, a US-based organization, in November 2023, stated that the wellness economy accounted for 5.6% of global economic output in 2022 and is expected to reach $8.5 trillion by 2027, growing at an average annual rate of 8.6%. Consequently, the increasing adoption of changing lifestyles is fueling the growth of the menopause market.

How Is The Menopause Market Broken Down By Segment Categories?

The menopause market covered in this report is segmented –

1) By Treatment: Dietary Supplements, Over-The-Counter (OTC) Pharma Products

2) By Route Of Administration: Topical, Oral, Injectables

3) By Distribution Channel: Hospital, Retail, Online Pharmacies

4) By End User: Hospital, Diagnostic Centers, Specialty Clinics, Other End Users

Subsegments:

1) By Dietary Supplements: Herbal Supplements, Vitamins And Minerals, Phytoestrogens, Omega-3 Fatty Acids, Probiotics

2) By Over-The-Counter (OTC) Pharma Products: Hormone Replacement Therapy (HRT), Non-Hormonal OTC Products, Antidepressants For Mood Swings, Sleep Aids, Pain Relievers

What Trends Are Transforming The Menopause Market?

Leading companies within the menopause market are prioritizing the development of novel therapies, including dual neurokinin 1/neurokinin 3 (NK1/NK3) receptor antagonists, to offer hormone-free alternatives for vasomotor symptoms (hot flashes and night sweats) and enhance the quality of life for menopausal women. Dual neurokinin 1/neurokinin 3 receptor antagonists describe oral pharmaceutical agents that concurrently obstruct both NK1 and NK3 receptors in the hypothalamus, thereby modulating the neuropeptide pathways responsible for thermoregulation and sweat responses, which lessens the frequency and severity of hot flashes and associated sleep disturbances. For example, in October 2025, Bayer AG, a Germany-based pharmaceutical company, secured approval from the U.S. Food and Drug Administration (FDA) for Lynkuet (elinzanetant) 60 mg capsules. This product represents the world’s first dual-NK1/NK3 receptor antagonist approved for treating moderate to severe hot flashes attributed to menopause. Lynkuet offers once-daily bedtime dosing, has demonstrated notable reductions in both the frequency and severity of hot flashes across three Phase III trials (OASIS 1/2/3), and functions via a non-hormonal mechanism of action, thus broadening treatment options for women for whom hormone therapy is contraindicated.

Which Players Are Present In The Menopause Market Space?

Major companies operating in the menopause market are Pfizer Inc., Johnson & Johnson Inc., The Procter & Gamble Company, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A, Abbott Laboratories Ltd., GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Rainbow Light Nutritional Systems LLC, Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex SpA, Pure Encapsulations LLC., Mylan N.V., Serenity Pharmaceuticals LLC

Get The Full Menopause Market Report:

https://www.thebusinessresearchcompany.com/report/menopause-global-market-report

Which Region Represents The Largest Share Of The Menopause Market?

North America was the largest region in the menopause market in 2025. The regions covered in the menopause market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Menopause Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/menopause-global-market-report

Browse Through More Reports Similar to the Global Menopause Market 2026, By The Business Research Company

Menopause Market Report 2026

https://www.thebusinessresearchcompany.com/report/menopause-global-market-report

Vasomotor Menopausal Symptoms Vms Treatment Market Report

https://www.thebusinessresearchcompany.com/report/vasomotor-menopausal-symptoms-vms-treatment-global-market-report

Hormone Therapy Market Report

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795